Treatment of chronic wounds: State of the art and future concepts

Cells Tissues Organs

Volumn 172, Issue 2, 2002, Pages 105-117

  Eming, Sabine A ^a   Smola, Hans ^b   Krieg, Thomas ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b B Braun Melsungen AG   (Germany)

Author keywords

Gene transfer; Growth factor wound therapy; Skin equivalents; Wound therapy; Wounds, chronic

Indexed keywords

ADENOVIRUS VECTOR; ANTIBIOTIC AGENT; CHLORHEXIDINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; HEXACHLOROPHENE; HYALURONIC ACID; HYDROGEN PEROXIDE; IODINE; NITRIC OXIDE SYNTHASE; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED WOUND HEALING FACTOR; QUATERNARY AMMONIUM DERIVATIVE; SILVER; UNCLASSIFIED DRUG; GROWTH PROMOTOR;

ARTICLE; CLINICAL TRIAL; DEBRIDEMENT; DEGRADATION; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; EPITHELIZATION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GRANULATION TISSUE; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SKIN GRAFT; TISSUE REPAIR; WOUND; WOUND DRESSING; WOUND HEALING; ANIMAL; BIOSYNTHESIS; CHRONIC DISEASE; CULTURE TECHNIQUE; GENETIC ENGINEERING; GENETICS; INJURY; METHODOLOGY; PHYSIOLOGY; PROTECTIVE CLOTHING; REVIEW; TISSUE TRANSPLANTATION;

ANIMALIA;

ANIMALS; CHRONIC DISEASE; CULTURE TECHNIQUES; GENE THERAPY; GENETIC ENGINEERING; GROWTH SUBSTANCES; HUMANS; OCCLUSIVE DRESSINGS; TISSUE TRANSPLANTATION; WOUND HEALING; WOUNDS AND INJURIES;

EID: 0036440651     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065611     Document Type: Article

References (89)

1. Andree, C., W.F. Swain, C.P. Page, M.D. Macklin, J. Slama, D. Hatzis, E. Eriksson (1994) In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proc Natl Acad Sci USA 91: 12188-12192.
2. Arons, J.A., D.J. Wainwright, R.E. Joran (1992) The surgical applications and implications of cultured human epidermis: A comprehensive review. Surgery 111: 4-11.
3. Atri, S.C., J. Misra, D. Bishet, et al (1990) Use of homologous platelet factors in achieving total healing of recalcitrant skin ulcers. Surgery 108: 508-514.
4. Baragi, V.M., R.R. Renkiewicz, H. Jordan, J. Bonadio, J.W. Hartmann (1995) Transplantation of transduced chondrocytes protects articular cartilage from IL-1 induced extracellular matrix degradation. J Clin Invest 96: 2454-2460.
5. Bell, E., H.P. Ehrlich, D.J. Buttle, T. Nakatsuji (1981) Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 211: 1052-1054.
6. Benn, S.I., J.S. Whitsitt, K.N. Broadley, L.B. Nanney, D. Perkins, L. He, M. Patel, J.R. Morgan, W.F. Swain, J.M. Davidson (1996) Enhancement of wound healing in rat skin following particle bombardment with cDNAs encoding TGF-b1. J Clin Invest 98: 2894-2902.
7. Bennett, N.T., G.S. Schultz (1993) Growth factors and wound healing: Biochemical properties of growth factors and their receptors. Am J Surg 165: 728-737.
8. Bonadio, J., E. Smily, P. Patil, S. Goldstein (1999) Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration. Nat Med 5: 753-759.
9. Boyce, S.T., M.J. Goretsky, D.G. Greenhalgh, R.J. Kagan, M.T. Rieman, G.D. Warden (1995) Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns. Ann Surg 222: 743-752.
10. Brown, G.L., L.B. Nanney, J. Griffin, et al (1989) Enhancement of wound healing by topical treatment with EGF. N Engl J Med 321: 76-79.
11. Burke, A.M., I.V. Yannas, W.C. Quinby, C.C. Bondoc, W.K. Jung (1981) Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg 194: 413-428.
12. Cheng, L., P.R. Ziegelhoffer, N.S. Yang (1993) In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc Natl Acad Sci USA 90: 4455-4459.
13. Ciernik, I.F., B.H. Krayenbühl, D.P. Carbone (1996) Puncture-mediated gene transfer to the skin. Hum Gene Ther 7: 893-899.
14. Clark, R.A.F. (1985) Cutaneous tissue repair: Basic biologic considerations. Am Acad Dermatol 13: 701-725.
15. da Costa, R.M., F.M. Ribeiro Jesus, C. Aniceto, M. Mendes (1999) Randomized, double-blind, placebo controlled, dose-ranging study of Gm-CSF in patients with chronic venous leg ulcers. Wound Repair Regen 7: 17-25.
16. Dyson, M., S. Young, C. Pendle (1988) Comparison of the effects of moist and dry conditions on dermal repair. J Invest Dermatol 91: 434-439.
17. Eaglstein, W.H. (1998) Dermagraft treatment of diabetic ulcers. J Dermatol 25: 803-804.
18. Eaglstein, W.H., V. Falanga (1998) Tissue engineering and the development of Apligraf a human skin equivalent. Adv Wound Care 11(4 suppl): 1-8.
19. Eming, S.A., J. Lee, R.G. Snow, R.G. Tompkins, M.L. Yarmush, J.R. Morgan (1995) Genetically modified human epidermis overexpressing PDGF-A directs the development of a cellular and vascular connective tissue stroma when transplanted to athymic mice. J Invest Dermatol 105: 756-763.
20. Eming, S.A., D.A. Medalie, R.G. Tompkins, M.L. Yarmush, J.R. Morgan (1998) Genetically modified human keratinocytes overexpressing PDGF-A enhance the performance of a composite skin graft. Hum Gene Ther 9: 529-539.
21. Eming, S.A., J.R. Morgan, A. Berger (1997) Gene therapy for tissue repair: Approaches and prospects. Br J Plast Surg 50: 491-500.
22. Eming, S.A., R.G. Snow, M.L. Yarmush, J.R. Morgan (1996) Targeted expression of IGF-1 to human keratinocytes: Modification of the autocrine control of keratinocyte proliferation. J Invest Dermatol 106: 113-120.
23. Eming, S.A., J.S. Whitsitt, L. He, T. Krieg, J.R. Morgan, J.M. Davidson (1999) Particle-mediated gene transfer of PDGF isoforms promotes wound repair. J Invest Dermatol 112: 297-302.
24. Eriksson, E., F. Yao, T. Svensjö, T. Winkler, J. Slama, M.D. Macklin, C. Andree, M. McGregor, V. Hinshaw, W.F. Swain (1998) In vivo gene transfer to skin and wound by microseeding. J Surg Res 78: 85-91.
25. Falanga, V. (1992) Growth factors and chronic wounds: The need to understand the microenvironment. J Dermatol 19: 667-672.
26. Falanga, V. (1993) Chronic wounds: Pathophysiologic and experimental considerations. J Invest Dermatol 100: 721-725.
27. Falange, V., D. Margolis, O. Alvarez, M. Auletta, F. Maggiacomo, M. Altman, et al (1998) Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch Dermatol 134: 293-300.
28. Fan, H., Q. Lin, G.R. Morrissey, P.A. Khavari (1999) Immunization via hair follicles by topical application of naked DNA to normal skin. Nat Biotechnol 17: 870-872.
29. Felgner, P.L., G. Rhodes (1991) Gene therapeutics. Nature 349: 351-352.
30. Felgner, P.L., G.M. Ringold (1989) Cationic liposome-mediated transfection. Nature 337: 387-388.
31. Fenjves, E.S., J. Smith, S. Zaradic, L.B. Taichman (1994) Systemic delivery of secreted protein by grafts of epidermal keratinocytes: Prospects for keratinocyte gene therapy. Hum Gene Ther 5: 1241-1248.
32. Friedmann, T. (1992) A brief history of gene therapy. Nat Genet 2: 93-98.
33. Fujisate, T., T. Sajiki, O. Liu, Y. Ikada (1996) Effects of bFGF on cartilage regeneration in chondrocyte-seeded sponge scaffold. Biomaterials 17: 155-162.
34. Gentzkow, G.D., S.D. Iwasaki (1996) Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 19: 350-354.
35. Gerrard, A.J., D.L. Hudson, G.G. Brownlee, F.M. Watt (1993) Towards gene therapy for haemophilia B using primary human keratinocytes. Nat Genet 3: 180-183.
36. Ghazizadeh, S., R. Harrington, L. Taichman (1999) In vivo transduction of mouse epidermis with recombinant retroviral vectors: Implications for cutaneous gene therapy. Gene Ther 6: 1267-1275.
37. Heimbach, D., A. Luterman, J. Burke, A. Cram, D. Herndon, J. Hunt, M. Jordan, et al (1988) Artificial dermis for major burns. Ann Surg 208: 313-320.
38. Hengge, U.R., E.F. Chan, R.A. Foster, P.S. Walker, J.C. Vogel (1995) Cytokine gene expression in epidermis with both biological effects following injection of naked DNA. Nat Genet 10: 161-166.
39. Hengge, U.R., L.B. Taichman, P. Kaur, G. Rogers, T.G. Jensen, L.A. Goldsmith, J.L. Rees, A.M. Christiano (1999) How realistic is cutaneous gene therapy? Exp Dermatol 8: 419-431.
40. Hoeffler, W.K., C.K. Wang, C. Matsui (1995) Phenotypic reversion of junctional epidermolysis bullosa keratinocytes by introduction of a therapeutic laminin 5 chain gene. J Invest Dermatol 104: 597.
41. Holloway, G.A., D.L. Steed, M.J. deMarco, et al (1993) A randomized, controlled multicenter, dose response trial of activated platelet supernatant, topical CT-102 in chronic, non-healing, diabetic wounds. Wounds 5: 198-201.
42. Khavari, P.A. (1997) Therapeutic gene delivery to the skin. Mol Med Today 3: 533-538.
43. Khavari, P.A., G.G. Krueger (1997) Cutaneous gene delivery. Adv Clin Res 5: 27-35.
44. Klein, T.M., E.D. Wolf, R. Wu, J.C. Sanford (1987) High-velocity microprojectiles for delivering nucleic acids into living cells. Nature 327: 70-73.
45. Knighton, D.R., K. Ciresi, V.D. Fiegel, S. Schumeth, E. Butler, F. Cerra (1990) Stimulation of repair in chronic non-healing cutaneous ulcers using PDWHF. Surg Gynecol Obstet 170: 56-60.
46. Knighton, D.R., G.D. Phillips, V.D. Fliegel (1986) Classification and treatment of chronic non-healing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 204: 322-330.
47. Krueger, G.G., J.R. Morgan, C.M. Jorgensen, L. Schmidt, H.L. Li, M.K, Kwan, S.T. Boyce, H.S. Wiley, J. Kaplan, M.J. Petersen (1994) Genetically modified skin to treat disease: Potential and limitations. J Invest Dermatol 103: 76S-84S.
48. Lauer, G., S. Sollberg, M. Cole, I. Flamme, J. Stürzebecher, K. Mann, T. Krieg, S.A. Eming (2000) Expression and proteolysis of VEGF is increased in chronic wounds. J Invest Dermatol 115: 12-18.
49. Lawrene, T., R.F. Diegelman (1994) Growth factors in wound healing. Clin Dermatol 12: 157-169.
50. Lee, J.I., L.B. Taichman (1989) Transient expression of a transfected gene in cultured epidermal keratinocytes: Implications for future studies. J Invest Dermatol 92: 267-271.
51. Li, L., R.M. Hoffman (1995) The feasibility of targeted selective gene therapy of the hair follicle. Nat Genet 1: 705-706.
52. Liechty, K.W., M. Nesbit, M. Herlyn, A. Radu, N.S. Adzick, T.M. Crombleholme (1999) Adenoviral-mediated overexpression of PDGF-B corrects ischemic impaired wound healing. J Invest Dermatol 113: 375-383.
53. Lu, B., G. Scott, L.A. Goldsmith (1995) A model for keratinocyte gene therapy: Preclinical and therapeutic considerations. Proc Assoc Am Phys 108: 165-172.
54. Machens, H.G., J.R. Morgan, F. Berthiaume, P. Stefanovich, R. Reimer, A.C. Berger (1998) Genetically modified fibroblasts induce angiogenesis in the rat epigastric island flap. Langenbecks Arch Surg 383: 345-350.
55. Martin, P. (1997) Wound healing - Aiming for perfect skin regeneration. Science 276: 75-81.
56. Morgan, J.R., Y. Barrandon, H. Green, R.C. Mulligan (1987) Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science 237: 1476-1479.
57. Morgan, J.R., R.G. Tompkins, M.L. Yarmush (1993) Advances in recombinant retroviruses for gene delivery. Adv Drug Deliv Rev 12: 143-158.
58. Mouillier, P., D. Bohl, J.M. Heard, O. Danos (1993) Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts. Nat Genet 4: 154-159.
59. Muhlhauser, J., R. Pili, M.J. Merrill, H. Maeda, A. Passaniti, R.G. Crystal, M.C. Capogrossi (1995) In vivo angiogenesis induced by recombinant adenovirus vectors coding either for secreted or nonsecreted forms of aFGF. Hum Gene Ther 6: 1457-1465.
60. Mulligan, R.C. (1993) The basic science of gene therapy. Science 260: 926-932.
61. Naldini, L., U. Blömer, P. Gallay, D. Ory, R. Mulligan, F.H. Gage, I.M. Verma, D. Trono (1996) In vivo delivery and stable transduction of non-dividing cells by a lentiviral vector. Science 272: 263-267.
62. Nakamura, N., K. Shino, T. Natsuume, S. Horibe, N. Matsumoto, Y. Kaneda, T. Ochi (1998) Early biological effect of in vivo gene transfer of PDGF-B into healing patellar ligament. Gene Ther 5: 1165-1170.
63. Odland, G. (1958) The fine structure of the interrelationship of cells in the human epidermis. J Biophys Biochem Cytol 4: 529-535.
64. Palmer, T.D., G.J. Rosman, W.R.A. Osborne, A.D. Miller (1991) Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc Natl Acad Sci USA 88: 1330-1334.
65. Parenteau, N.C., C.M. Nolte, P.R. Belbo, M. Rosenberg, L.M. Wilkins, E.W. Johnson, S. Watson, V.S. Mason, E. Bell (1991) Epidermis generated in vitro: Practical considerations and applications. J Cell Biochem 45: 245-251.
66. Phillips, T.J., J.S. Dover (1991) Leg ulcers. J Am Acad Dermatol 25: 965-987.
67. Phillips, T.J., B Gilchrist (1992) Clinical applications of cultured epithelium. Epithelial Cell Biol 1: 39-46.
68. Rheinwald, J.G., H. Green (1975) Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells. Cell 6: 331-343.
69. Scharffetter-Kochanek, K., C. Meewes, S.A. Eming, J. Dissemond, N. Hani, J. Wenk, M. Wlaschek, P. Brenneisen (1999) Chronische wunden und wachstumsfaktoren. Z Hautkr 74: 664-672.
70. Schmeller, W., Y Gaber (2000) Surgical removal of ulcer and lipodermatosclerosis followed by split-skin grafting (shave therapy) yields good long-term results in nonhealing venous leg ulcers. Acta Derm Venereol 80: 267-271.
71. Schiedner, G., N. Moral, R.J. Parks, Y. Wu, S.C. Koopamans, C. Langston, F.L. Graham, A.L. Beaudet, S Kochanek (1998) Genomic DNA transfer with high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat Genet 18: 180-183.
72. Shea, L.D., E. Smiley, J. Bonadio, D.J. Mooney (1999) DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 17: 551-554.
73. Singer, A.J., R.A.F. Clark (1999) Cutaneous wound healing. Lancet 341: 738-746.
74. Smola, H., G. Thiekotter, N.E. Fusenig (1993) Mutual induction of growth factor gene expression by epidermal-dermal cell interaction. J Cell Biol 122: 417-429.
75. Smola, H., H.J. Stark, G. Thiekotter, N. Mirancea, T. Krieg, N.E. Fusenig (1998) Dynamics of basement membrane formation by keratinocyte-fibroblast interactions in organotypic skin culture. Exp Cell Res 239: 399-410.
76. Steed, D.L. (1995) Clinical evaluation of rh PDGF for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J Vasc Surg 21: 71-81.
77. Sun, W.H., J.K. Burkholder, J. Sun, J. Culp, J. Turner, X.G. Lu, T.D. Pugh, W.B. Ershler, N.S. Yang (1995) In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Proc Natl Acad Sci USA 92: 2889-2893.
78. Sun, L., L. Xu, H. Chang, F.A. Henry, R.M. Miller, J.M. Harmon, T.B. Nielsen (1997) Transfection with aFGF cDNA improves wound healing. J Invest Dermatol 108: 313-318.
79. Terskikh, V.V., A.V. Vasiliev (1999) Cultivation and transplantation of epidermal keratinocytes. Int Rev Cytol 188: 41-72.
80. Tio, R.A., J.M. Isner, K. Walsh (1998) Gene therapy to prevent restenosis: The Boston experience. Semin Interv Cardiol 3: 205-210.
81. Vogt, P.M., S. Thompson, C. Andree, P. Liu, K. Breuing, D. Hatzis, H. Brown, R.C. Mulligan, E. Eriksson (1994) Genetically modified keratinocytes transplanted to wounds reconstitute the epidermis. Proc Natl Acad Sci USA 91: 9307-9311.
82. Wiemann, T.S., J.M. Smiell, Y. Su (1998) Efficacy and safety of rh PDGF-BB (becaplermin) in patients with non-healing lower extremity diabetic ulcer: A phase III randomized, double blind study. Diabetes Care 21: 821-827.
83. Williams, R.S., s.A. Johnston, M. Riedy, M.J. DeVit, S.G. McElligott, J.C. Sanford (1991) Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc Natl Acad Sci USA 88: 2726-2730.
84. Winter, G.D. (1962) Formation of scab and the rate of epithelialization of superficial wounds in the skin of the young domestic pig. Nature 193: 293-294.
85. Wlaschek, M., D. Peus, V. Achterberg, W. Meyer-Ingold, K. Scharffetter-Kochanek (1997) Protease inhibitors protect growth factor activity in chronic wounds. Br J Dermatol 137: 646.
86. Yamasaki, K., H.D.J. Edlington, C. McClosky, E. Tzeng, A. Lizonova, I. Kovesdi, D.L. Steed, T.R. Billiar (1998) Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J Clin Invest 101: 967-971.
87. Yang, N.S., J. Burkholder, B. Roberts, B. Martinell, D. McCabe (1990) In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci USA 87: 9568-9572.
88. Yang, N.S., D.E. McCabe, W.F. Swain (1997) Methods for particle-mediated gene transfer into skin; in Robbinson, P.D. (ed): Gene Therapy Protocols. Totowa, Humana Press, pp 281-296.
89. Yang, N.S., W.H. Sun (1995) Gene gun and other non-viral approaches for cancer gene therapy. Nat Med 1: 481-483.